Timothy C Barabe, Director at Cartesian Therapeutics RNAC, reported a large exercise of company stock options on November 15, according to a new SEC filing. What Happened: A Form 4 filing from the U.S ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results